Application of terazosin for preparing medicines for treating postpartum urinary retention
A technology for postpartum urinary retention and terazosin, which is applied in drug combinations, pharmaceutical formulas, and diseases of the urinary system to achieve the effects of reducing urethral resistance, eliminating local edema, and facilitating administration
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0007] For the pharmacological effects of terazosin, we applied terazosin 1-2mg / time / day to treat patients with postpartum urinary retention, and studied its clinical efficacy.
[0008] The clinical experiment observation of medicine of the present invention:
[0009] (1) Observation objects: Among the 2,600 vaginal delivery women from January 2002 to October 2005, 68 had different degrees of postpartum urinary retention. Weight 3400-4200g, age 25-31 years old, average age 27 years old, all underwent left episiotomy, no postpartum hemorrhage and bladder, urethral tear. There was no normal urination 8 hours after delivery, the fundus of the bladder was located between the umbilicus and pubic region, and treatment such as drainage failed.
[0010] (2) Oral administration of terazosin 2mg / time / day, initial dose 1mg / time / day, in order to consolidate the curative effect, take it for 2-3 days. It is not clear whether Intrazosin is secreted in breast milk, so it is recommended to s...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com